Prabin Shrestha

636 total citations
20 papers, 287 citations indexed

About

Prabin Shrestha is a scholar working on Genetics, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Prabin Shrestha has authored 20 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Surgery and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Prabin Shrestha's work include Glioma Diagnosis and Treatment (3 papers), Gastroesophageal reflux and treatments (2 papers) and Antimicrobial agents and applications (2 papers). Prabin Shrestha is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), Gastroesophageal reflux and treatments (2 papers) and Antimicrobial agents and applications (2 papers). Prabin Shrestha collaborates with scholars based in United States, Japan and Nepal. Prabin Shrestha's co-authors include Kaoru Kurisu, Tit-Yee Wong, Fumiyuki Yamasaki, Yongmei Zhang, Kazuhiko Sugiyama, Wen‐Jen Chen, Csaba P. Kövesdy, Shigeyuki Sakamoto, Masaaki Shibukawa and Kamyar Kalantar‐Zadeh and has published in prestigious journals such as Cancer, Journal of the American Society of Nephrology and Mayo Clinic Proceedings.

In The Last Decade

Prabin Shrestha

16 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prabin Shrestha United States 9 60 55 39 37 36 20 287
Carolyn Gill United Kingdom 14 27 0.5× 11 0.2× 36 0.9× 44 1.2× 11 0.3× 36 798
Jun‐Ho Kim South Korea 11 66 1.1× 13 0.2× 57 1.5× 58 1.6× 9 0.3× 32 338
Tomasz Olszowski Poland 11 29 0.5× 30 0.5× 52 1.3× 62 1.7× 3 0.1× 23 455
Hui Jeong An South Korea 13 35 0.6× 39 0.7× 40 1.0× 134 3.6× 16 0.4× 47 455
Myeong Jin Lee Japan 13 151 2.5× 14 0.3× 96 2.5× 225 6.1× 8 0.2× 32 566
Hamide Sayar Türkiye 11 64 1.1× 6 0.1× 121 3.1× 50 1.4× 12 0.3× 41 404
Yuantao Wang China 12 57 0.9× 13 0.2× 102 2.6× 102 2.8× 6 0.2× 40 356
Željka Večerić‐Haler Slovenia 10 30 0.5× 6 0.1× 63 1.6× 107 2.9× 8 0.2× 24 433
Serkan Şenol Türkiye 13 58 1.0× 38 0.7× 144 3.7× 82 2.2× 8 0.2× 55 482
JN Gordon United Kingdom 5 61 1.0× 10 0.2× 31 0.8× 144 3.9× 18 0.5× 9 472

Countries citing papers authored by Prabin Shrestha

Since Specialization
Citations

This map shows the geographic impact of Prabin Shrestha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prabin Shrestha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prabin Shrestha more than expected).

Fields of papers citing papers by Prabin Shrestha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prabin Shrestha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prabin Shrestha. The network helps show where Prabin Shrestha may publish in the future.

Co-authorship network of co-authors of Prabin Shrestha

This figure shows the co-authorship network connecting the top 25 collaborators of Prabin Shrestha. A scholar is included among the top collaborators of Prabin Shrestha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prabin Shrestha. Prabin Shrestha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sumida, Keiichi, et al.. (2025). Comparative Effectiveness of Lubiprostone and Stool Softeners on Risk of Kidney Outcomes in Patients with CKD. Clinical Journal of the American Society of Nephrology. 20(10). 1341–1351.
2.
Shrestha, Prabin, et al.. (2025). Trends in Opioid Prescriptions and Short-term Mortality Outcomes for Patients With Chronic Kidney Disease and Chronic Pain. Mayo Clinic Proceedings. 100(7). 1248–1251.
3.
4.
Sumida, Keiichi, Prabin Shrestha, Fridtjof Thomas, et al.. (2024). Anti–Tumor Necrosis Factor Therapy and Risk of Kidney Function Decline and Mortality in Inflammatory Bowel Disease. JAMA Network Open. 7(4). e246822–e246822. 2 indexed citations
5.
Sumida, Keiichi, Prabin Shrestha, Fridtjof Thomas, et al.. (2024). Incident Diuretic Use and Subsequent Risk of Bone Fractures. Mayo Clinic Proceedings. 99(6). 913–926. 2 indexed citations
6.
Shrestha, Prabin, et al.. (2024). Lubiprostone Use and Kidney Outcomes in Patients with CKD and Constipation: A Large, Nationwide, Observational Study of US Veterans. Journal of the American Society of Nephrology. 35(10S).
7.
Shrestha, Prabin, Keiichi Sumida, Fridtjof Thomas, et al.. (2023). Association of oral iron replacement therapy with kidney failure and mortality in CKD patients. Clinical Kidney Journal. 16(11). 2082–2090. 4 indexed citations
8.
Shrestha, Prabin, Keiichi Sumida, Fridtjof Thomas, et al.. (2023). Association of iron therapy with incidence of chronic kidney disease. European Journal Of Haematology. 111(6). 872–880. 2 indexed citations
9.
Lü, Jun, Prabin Shrestha, Elani Streja, Kamyar Kalantar‐Zadeh, & Csaba P. Kövesdy. (2023). Association of long-term aspirin use with kidney disease progression. Frontiers in Medicine. 10. 1283385–1283385. 4 indexed citations
10.
Shrestha, Prabin, Keiichi Sumida, Fridtjof Thomas, et al.. (2022). Association of Uric Acid–Lowering Therapy With Incident Chronic Kidney Disease. JAMA Network Open. 5(6). e2215878–e2215878. 47 indexed citations
11.
Shrestha, Prabin, Yongmei Zhang, Wen‐Jen Chen, & Tit-Yee Wong. (2020). Triclosan: antimicrobial mechanisms, antibiotics interactions, clinical applications, and human health. PubMed. 38(3). 245–268. 49 indexed citations
12.
Shrestha, Prabin, Jie Ni, & Tit-Yee Wong. (2020). Synergistic and antagonistic interactions of triclosan with various antibiotics in bacteria. PubMed. 38(3). 187–203. 9 indexed citations
13.
Shrestha, Prabin, et al.. (2016). Isolation and Physicochemical Characterization of Laccase fromGanoderma lucidum-CDBT1 Isolated from Its Native Habitat in Nepal. BioMed Research International. 2016. 1–10. 32 indexed citations
14.
Pant, Basant, et al.. (2011). Intraventricular Taenia solium Neurocysticercosis: A Report of Three Cases. Journal of Nepal Medical Association. 51(184). 192–5. 7 indexed citations
15.
Tominaga, Atsushi, Vishwa Jeet Amatya, Megu Ohtaki, et al.. (2009). Role of PROPELLER diffusion weighted imaging and apparent diffusion coefficient in the diagnosis of sellar and parasellar lesions. European Journal of Radiology. 74(3). 420–427. 29 indexed citations
16.
Yamasaki, Fumiyuki, Masahiro Kenjo, Prabin Shrestha, et al.. (2008). Secondary anaplastic oligodendroglioma after cranial irradiation: a case report. Journal of Neuro-Oncology. 88(3). 299–303. 8 indexed citations
17.
Shrestha, Prabin, et al.. (2007). P1-182: Responses of total antioxidant status amongst lung cancer patients. Journal of Thoracic Oncology. 2(8). S809–S810. 1 indexed citations
18.
Sakamoto, Shigeyuki, Yoshihiro Kiura, Fumiyuki Yamasaki, et al.. (2007). Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease. Neurosurgical Review. 31(1). 77–81. 56 indexed citations
19.
Shrestha, Prabin, Taiichi Saito, Seiji Hama, et al.. (2007). Geminin: A good prognostic factor in high‐grade astrocytic brain tumors. Cancer. 109(5). 949–956. 22 indexed citations
20.
Yamaguchi, Satoshi, Kuniki Eguchi, Masaaki Takeda, et al.. (2007). Penetrating Injury of the Upper Cervical Spine by a Chopstick -Case Report-. Neurologia medico-chirurgica. 47(7). 328–330. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carolyn Gill Breakdown of academic impact, for papers by Jun‐Ho Kim Breakdown of academic impact, for papers by Tomasz Olszowski Breakdown of academic impact, for papers by Hui Jeong An Breakdown of academic impact, for papers by Myeong Jin Lee Breakdown of academic impact, for papers by Hamide Sayar Breakdown of academic impact, for papers by Yuantao Wang Breakdown of academic impact, for papers by Željka Večerić‐Haler Breakdown of academic impact, for papers by Serkan Şenol Breakdown of academic impact, for papers by JN Gordon
Rankless by CCL
2026